204 related articles for article (PubMed ID: 1732950)
1. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
[TBL] [Abstract][Full Text] [Related]
2. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
3. Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma.
Israel O; Mor M; Epelbaum R; Frenkel A; Haim N; Dann EJ; Gaitini D; Bar-Shalom R; Kolodny GM; Front D
Cancer; 2002 Feb; 94(4):873-8. PubMed ID: 11920453
[TBL] [Abstract][Full Text] [Related]
4. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
[TBL] [Abstract][Full Text] [Related]
5. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Vose JM; Bierman PJ; Anderson JR; Harrison KA; Dalrymple GV; Byar K; Kessinger A; Armitage JO
J Clin Oncol; 1996 Sep; 14(9):2473-9. PubMed ID: 8823325
[TBL] [Abstract][Full Text] [Related]
6. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
7. Ga-67 SPECT before and after treatment of lymphoma.
Front D; Israel O; Epelbaum R; Ben Haim S; Sapir EE; Jerushalmi J; Kolodny GM; Robinson E
Radiology; 1990 May; 175(2):515-9. PubMed ID: 2183289
[TBL] [Abstract][Full Text] [Related]
8. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
9. The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma.
Tuli MM; Al-Shemmari SH; Ameen RM; Al-Muhanadi S; Al-Huda FA; Ballani N; Khoshi M; Al-Enezi F; Bajciova V; Mottl H
Clin Lymphoma; 2004 Jun; 5(1):56-61. PubMed ID: 15245609
[TBL] [Abstract][Full Text] [Related]
10. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography scanning in the assessment of patients with lymphoma.
Foo SS; Mitchell PL; Berlangieri SU; Smith CL; Scott AM
Intern Med J; 2004 Jul; 34(7):388-97. PubMed ID: 15271172
[TBL] [Abstract][Full Text] [Related]
12. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients.
Front D; Israel O
Semin Nucl Med; 1995 Jan; 25(1):60-71. PubMed ID: 7716559
[TBL] [Abstract][Full Text] [Related]
13. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
14. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma.
Rehm PK
Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma: evaluation with Ga-67 SPECT.
Tumeh SS; Rosenthal DS; Kaplan WD; English RJ; Holman BL
Radiology; 1987 Jul; 164(1):111-4. PubMed ID: 3495815
[TBL] [Abstract][Full Text] [Related]
16. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma].
Monzawa S; Karikomi M; Uno K; Itami J; Arimizu N
Gan No Rinsho; 1988 Aug; 34(9):1059-64. PubMed ID: 3172511
[TBL] [Abstract][Full Text] [Related]
17. Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance?
Bar-Shalom R; Israel O; Haim N; Leviov M; Epelbaum R; Frenkel A; Ben-Haim S; Kolodny GM; Front D
Radiology; 1996 May; 199(2):473-6. PubMed ID: 8668797
[TBL] [Abstract][Full Text] [Related]
18. [Use of Ga-67 SPECT in patients with malignant lymphoma after primary chemotherapy for further treatment planning: comparison with spiral CT].
Stroszczynski C; Amthauer H; Hosten N; Mapara M; Ricke J; Jochens R; Fischer-Funk E; Ludwig WD; Eichstädt H; Felix R
Rofo; 1997 Nov; 167(5):458-66. PubMed ID: 9440890
[TBL] [Abstract][Full Text] [Related]
19. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
Zollars LE; Nagel JS; Tumeh SS
J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy.
Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
Radiology; 1999 Feb; 210(2):487-91. PubMed ID: 10207434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]